Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation of people shedding the infectious virus in biological materials with high viral loads. Of 129 swab specimens, 63 were positive in the Espline test and 25 in the RT-PCR test.

Related Post